T. Rowe Price Associates »

Immix Biopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 415k 9.11

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Immix Biopharma

Henderson Group
Saturn V Capital Management
Eventide Asset Management
Vanguard Capital Management
Millennium Management
Marshall Wace
Logos Global Management
Bleichroeder
Franklin Resources
Velan Capital Investment Management
Susquehanna International
Blue Owl Capital Holdings
BlackRock
Geode Capital Management
LGT Fund Management

View all funds holding Immix Biopharma